Literature DB >> 15383701

Application of monoclonal antibody, specific for intracellular Orientia tsutsugamushi, to immunofluorescent antibody test for determining antibiotic susceptibility.

Mee-Kyung Kim1, Zagga Odgerel, Mi-Jeong Kim, Moon-Hyun Chung, Byung-Uk Lim, Jae-Seung Kang.   

Abstract

The simple quantification of viable intracellular bacteria is important for the study of an obligate intracellular bacterium, Orientia tsutsugamushi. We applied a novel monoclonal antibody (M686-13)--specific for intracellular Orientia--to an immunofluorescent antibody (IFA) test for determining antibiotic susceptibility of O. tsutsugamushi. M686-13 did not react with Orientia that was inhibited by doxycycline, although bacterial particles still remained in the cells. This preferential staining of proliferating bacteria made the IFA test rapid and precise. Using this method, we could successfully measure the minimal inhibitory concentration (MIC) of a Korean strain of O. tsutsugamushi to doxycycline and clindamycin. This method may be used in other procedures to evaluate the growth of Orientia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383701     DOI: 10.1111/j.1348-0421.2004.tb03475.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  2 in total

1.  Orientia tsutsugamushi Is Highly Susceptible to the RNA Polymerase Switch Region Inhibitor Corallopyronin A In Vitro and In Vivo.

Authors:  Fredericke Kock; Matthias Hauptmann; Anke Osterloh; Till F Schäberle; Sven Poppert; Hagen Frickmann; Klaus-Dieter Menzel; Gundela Peschel; Kenneth Pfarr; Andrea Schiefer; Gabriele M König; Achim Hoerauf; Bernhard Fleischer; Christian Keller
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

2.  Improved antibiotic susceptibility test of Orientia tsutsugamushi by flow cytometry using monoclonal antibody.

Authors:  Mi-Jeong Kim; Mee-Kyung Kim; Jae-Seung Kang
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.